A recombinant BCG vaccine generates a Th1‐like response and inhibits IgE synthesis in BALB/c mice
- 1 July 1999
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 97 (3), 515-521
- https://doi.org/10.1046/j.1365-2567.1999.00782.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway EosinophiliaThe Journal of Experimental Medicine, 1998
- Vaccination with a multi‐epitopic recombinant allergen induces specific immune deviation via T‐cell anergyImmunology, 1997
- Long‐Lasting Immune Response Induced by Recombinant Bacillus Calmette–Guérin (BCG) Secretion SystemScandinavian Journal of Immunology, 1996
- Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease.The Journal of Experimental Medicine, 1995
- Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I‐ and II‐deficient knock‐out mice: contribution of CD4 and CD8 T cells to acquired resistanceEuropean Journal of Immunology, 1995
- A potential vaccine strategy for asthma and allied atopic diseases during early childhoodThe Lancet, 1994
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to AllergensNew England Journal of Medicine, 1989
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970